Home Journal Club FAQ My Amedeo About Tranquillis Services Flying Publisher   

Books, Journals, Podcasts, Weekly Updates,
by Amedeo

  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Gut

Retrieve available abstracts of 118 articles:
HTML format
Text format



Single Articles


    February 2010
  1. ROGLER G
    The importance of gut microbiota in mediating the effect of NOD2 defects in inflammatory bowel disease.
    Gut. 2010;59:153-4.
    PubMed     Text format     Related articles   


  2. COLLINS CB , McNamee EN, Wermers JD, Lebsack MD, et al
    Chemokine decoy receptor D6 in inflammatory bowel disease (IBD) and IBD-associated colon cancer.
    Gut. 2010;59:151-2.
    PubMed     Text format     Related articles   


  3. PEYRIN-BIROULET L , Loftus EV Jr, Colombel JF, Sandborn WJ, et al
    Early Crohn disease: a proposed definition for use in disease-modification trials.
    Gut. 2010;59:141-7.
    PubMed     Text format     Related articles   


    December 2009
  4. YARKONI S , Sagiv Y, Kaminitz A, Askenasy N, et al
    Interleukin 2 targeted therapy in inflammatory bowel disease.
    Gut. 2009;58:1705-1706.
    PubMed     Text format     Related articles   


  5. BIANCONE L , Petruzziello C, Calabrese E, Zorzi F, et al
    Long-term safety of Infliximab for the treatment of inflammatory bowel disease: does blocking TNF{alpha} reduce colitis-associated colorectal carcinogenesis?
    Gut. 2009;58:1703.
    PubMed     Text format     Related articles   


  6. CARBONNEL F , Boutron MC
    Ulcerative colitis: is it in the diet?
    Gut. 2009;58:1577-1579.
    PubMed     Text format     Related articles   


    November 2009
  7. LI Y , de Haar C, Chen M, Deuring J, et al
    Disease-Related Expression of the IL-6 / STAT3 / SOCS3 Signaling Pathway in Ulcerative Colitis and Ulcerative Colitis-Related Carcinogenesis.
    Gut. 2009.
    PubMed     Text format     Related articles    Abstract available


  8. BOUMA G , Neve S, van Grieken NC, Mulder CJ, et al
    A Crohn's disease patient with pustules and fever.
    Gut. 2009;58:1537.
    PubMed     Text format     Related articles   


    October 2009
  9. SOKOL H , Beaugerie L
    Inflammatory bowel disease and lymphoproliferative disorders: the dust is starting to settle.
    Gut. 2009;58:1427-36.
    PubMed     Text format     Related articles    Abstract available


  10. MAJOR G
    "A flare" in a patient with known inflammatory bowel disease.
    Gut. 2009;58:1398.
    PubMed     Text format     Related articles   


  11. RAHIER JF , Yazdanpanah Y, Colombel JF, Travis S, et al
    The European (ECCO) Consensus on infection in IBD: what does it change for the clinician?
    Gut. 2009;58:1313-5.
    PubMed     Text format     Related articles   


  12. VALENTINE JF , Fedorak RN, Feagan B, Fredlund P, et al
    Steroid-sparing properties of sargramostim in patients with corticosteroid-dependent Crohn's disease: a randomised, double-blind, placebo-controlled, phase 2 study.
    Gut. 2009;58:1354-62.
    PubMed     Text format     Related articles    Abstract available


    September 2009
  13. ROVEDATTI L , Kudo T, Biancheri P, Sarra M, et al
    Differential regulation of interleukin-17 and interferon-{gamma} production in inflammatory bowel disease.
    Gut. 2009.
    PubMed     Text format     Related articles    Abstract available


  14. SHALE M , Ghosh S
    How intestinal epithelial cells tolerise dendritic cells and its relevance to inflammatory bowel disease.
    Gut. 2009;58:1291-9.
    PubMed     Text format     Related articles    Abstract available


  15. LOUIS E , Libioulle C, Reenaers C, Belaiche J, et al
    Genetics of ulcerative colitis: the come-back of interleukin 10.
    Gut. 2009;58:1173-6.
    PubMed     Text format     Related articles   


  16. WARREN EH
    Genetic risk for colitis-associated colorectal cancer.
    Gut. 2009;58:1177-9.
    PubMed     Text format     Related articles   


  17. SOKOL H , Polin V, Lavergne-Slove A, Panis Y, et al
    Plexitis as a predictive factor of early postoperative clinical recurrence in Crohn's disease.
    Gut. 2009;58:1218-25.
    PubMed     Text format     Related articles    Abstract available


  18. DAMBACHER J , Beigel F, Zitzmann K, De Toni EN, et al
    The role of the novel Th17 cytokine IL-26 in intestinal inflammation.
    Gut. 2009;58:1207-17.
    PubMed     Text format     Related articles    Abstract available


    August 2009
  19. ARIJS I , Li K, Toedter G, Quintens R, et al
    Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis.
    Gut. 2009.
    PubMed     Text format     Related articles    Abstract available


  20. AWAIS D , Siegel CA, Higgins PD
    Modeling Dysplasia Detection in Ulcerative Colitis: Clinical Implications of Surveillance Intensity.
    Gut. 2009.
    PubMed     Text format     Related articles    Abstract available


  21. SEOW CH , Newman A, Irwin SP, Steinhart AH, et al
    Trough Serum Infliximab: A Predictive Factor Of Clinical Outcome For Infliximab Therapy In Acute Ulcerative Colitis.
    Gut. 2009.
    PubMed     Text format     Related articles    Abstract available


  22. BENCHIMOL EI , Guttmann A, Griffiths AM, Rabeneck L, et al
    Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data.
    Gut. 2009.
    PubMed     Text format     Related articles    Abstract available


  23. BRAND S
    Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease.
    Gut. 2009;58:1152-67.
    PubMed     Text format     Related articles    Abstract available


  24. MUISE AM , Walters TD, Glowacka WK, Griffiths AM, et al
    Polymorphisms in E-cadherin (CDH1) result in a mis-localised cytoplasmic protein that is associated with Crohn's disease.
    Gut. 2009;58:1121-7.
    PubMed     Text format     Related articles    Abstract available


  25. RIGBY RJ , Hunt MR, Scull BP, Simmons JG, et al
    A new animal model of postsurgical bowel inflammation and fibrosis: the effect of commensal microflora.
    Gut. 2009;58:1104-12.
    PubMed     Text format     Related articles    Abstract available


    July 2009
  26. HART AR
    Linoleic Acid, a Dietary N-6 Polyunsaturated Fatty Acid, and the Aetiology of Ulcerative Colitis - A European Prospective Cohort Study.
    Gut. 2009.
    PubMed     Text format     Related articles    Abstract available


  27. PANES J , Salas A
    Mechanisms underlying the beneficial effects of stem cell therapies for inflammatory bowel diseases.
    Gut. 2009;58:898-900.
    PubMed     Text format     Related articles   


  28. MANI AR , Moore KP
    New insights into the role of endogenous opioids in the pathogenesis of gastrointestinal and liver disease.
    Gut. 2009;58:893-5.
    PubMed     Text format     Related articles   


  29. COLOMBEL JF , Schwartz DA, Sandborn WJ, Kamm MA, et al
    Adalimumab for the treatment of fistulas in patients with Crohn's disease.
    Gut. 2009;58:940-8.
    PubMed     Text format     Related articles    Abstract available


  30. GONZALEZ-REY E , Anderson P, Gonzalez MA, Rico L, et al
    Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis.
    Gut. 2009;58:929-39.
    PubMed     Text format     Related articles    Abstract available


  31. MENCHEN L , Marin-Jimenez I, Arias-Salgado EG, Fontela T, et al
    Matrix metalloproteinase 9 is involved in Crohn's disease-associated platelet hyperactivation through the release of soluble CD40 ligand.
    Gut. 2009;58:920-8.
    PubMed     Text format     Related articles    Abstract available


    June 2009
  32. DERER S , Waetzig GH, Seegert D, Nikolaus S, et al
    A possible link between TIMP-1 induction and response to infliximab.
    Gut. 2009;58:888.
    PubMed     Text format     Related articles   


  33. LOFFELD RJ
    Data selection flaw.
    Gut. 2009;58:887.
    PubMed     Text format     Related articles   


  34. BEVINS CL , Stange EF, Wehkamp J
    Decreased Paneth cell defensin expression in ileal Crohn's disease is independent of inflammation, but linked to the NOD2 1007fs genotype.
    Gut. 2009;58:882-3.
    PubMed     Text format     Related articles   


  35. ALBERT JG , Gittinger FS, Hainz M, Lubbert C, et al
    In disguise as an acute flare: an unusual differential diagnosis of Crohn's disease.
    Gut. 2009;58:742.
    PubMed     Text format     Related articles   


  36. SHALE M , Kaplan GG, Panaccione R, Ghosh S, et al
    Isotretinoin and intestinal inflammation: what gastroenterologists need to know.
    Gut. 2009;58:737-41.
    PubMed     Text format     Related articles   


  37. DI SABATINO A , Jackson CL, Pickard KM, Buckley M, et al
    Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures.
    Gut. 2009;58:777-89.
    PubMed     Text format     Related articles    Abstract available


  38. FOELL D , Wittkowski H, Roth J
    Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damage.
    Gut. 2009;58:859-68.
    PubMed     Text format     Related articles    Abstract available


    April 2009
  39. VAN LIMBERGEN J , Russell RK, Nimmo ER, Drummond HE, et al
    Germline variants of IRGM in childhood-onset Crohn's disease.
    Gut. 2009;58:610-1.
    PubMed     Text format     Related articles   


  40. OUSSALAH A , Bigard MA, Peyrin-Biroulet L
    Certolizumab use in pregnancy.
    Gut. 2009;58:608.
    PubMed     Text format     Related articles   


  41. FOCOSI D , Maggi F, Ceccherini-Nelli L, Marchi S, et al
    Progressive multifocal leukoencephalopathy in autoimmune disorders.
    Gut. 2009;58:605.
    PubMed     Text format     Related articles   


  42. SCHOLMERICH J
    Balancing the risks and benefits of prolonged use of infliximab.
    Gut. 2009;58:477-8.
    PubMed     Text format     Related articles   


  43. FUNKE B , Autschbach F, Kim S, Lasitschka F, et al
    Functional characterisation of decoy receptor 3 in Crohn's disease.
    Gut. 2009;58:483-91.
    PubMed     Text format     Related articles    Abstract available


  44. MARION-LETELLIER R , Dechelotte P, Iacucci M, Ghosh S, et al
    Dietary modulation of peroxisome proliferator-activated receptor gamma.
    Gut. 2009;58:586-93.
    PubMed     Text format     Related articles    Abstract available


  45. SCHNITZLER F , Fidder H, Ferrante M, Noman M, et al
    Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort.
    Gut. 2009;58:492-500.
    PubMed     Text format     Related articles    Abstract available


    March 2009
  46. ZEITOUN JD , Kaci R, Homsi T, Hermine O, et al
    Anal ulceration in a young man.
    Gut. 2009;58:403.
    PubMed     Text format     Related articles   


  47. TSENG CH , Liu KL, Liou JM, W HP, et al
    Abdominal distension in a patient with Crohn's disease.
    Gut. 2009;58:346.
    PubMed     Text format     Related articles   


  48. ATREYA I , Neurath MF
    Understanding the delayed onset of action of azathioprine in IBD: are we there yet?
    Gut. 2009;58:325-6.
    PubMed     Text format     Related articles   


  49. VERMEIRE S , Van Assche G, Rutgeerts P
    Genetic analysis to predict prognosis at the onset of Crohn's disease: not yet ready for prime time?
    Gut. 2009;58:323-4.
    PubMed     Text format     Related articles   


  50. TUIN A , Poelstra K, de Jager-Krikken A, Bok L, et al
    Role of alkaline phosphatase in colitis in man and rats.
    Gut. 2009;58:379-87.
    PubMed     Text format     Related articles    Abstract available


  51. BEN-HORIN S , Goldstein I, Fudim E, Picard O, et al
    Early preservation of effector functions followed by eventual T cell memory depletion: a model for the delayed onset of the effect of thiopurines.
    Gut. 2009;58:396-403.
    PubMed     Text format     Related articles    Abstract available


  52. WEERSMA RK , Stokkers PC, van Bodegraven AA, van Hogezand RA, et al
    Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort.
    Gut. 2009;58:388-95.
    PubMed     Text format     Related articles    Abstract available


    February 2009
  53. GARRITY-PARK MM , Loftus EV Jr, William SJ, Bryant S, et al
    MHC Class II alleles in ulcerative colitis-associated colorectal cancer.
    Gut. 2009.
    PubMed     Text format     Related articles    Abstract available


  54. FESTEN EA , Goyette P, Scott R, Annese V, et al
    Genetic Variants in the Region Harbouring IL2/IL21 Associated to Ulcerative Colitis.
    Gut. 2009.
    PubMed     Text format     Related articles    Abstract available


  55. TAUBERT D , Jung N, Goeser T, Schomig E, et al
    Increased ergothioneine tissue concentrations in carriers of the Crohn's disease risk-associated 503F variant of the organic cation transporter OCTN1.
    Gut. 2009;58:312-4.
    PubMed     Text format     Related articles   


  56. YAMAZAKI K , Takahashi A, Takazoe M, Kubo M, et al
    Positive association of genetic variants in the upstream region of NKX2-3 with Crohn's disease in Japanese patients.
    Gut. 2009;58:228-32.
    PubMed     Text format     Related articles    Abstract available


  57. WESTENDORF AM , Fleissner D, Groebe L, Jung S, et al
    CD4+Foxp3+ regulatory T cell expansion induced by antigen-driven interaction with intestinal epithelial cells independent of local dendritic cells.
    Gut. 2009;58:211-9.
    PubMed     Text format     Related articles    Abstract available


    January 2009
  58. RIMOLA J , Rodriguez S, Garcia Bosch O, Ordas I, et al
    Magnetic resonance for assessment of disease activity and severity in Crohn disease.
    Gut. 2009.
    PubMed     Text format     Related articles    Abstract available


  59. MANZ M , Beglinger C, Vavricka SR
    Fatal invasive pulmonary aspergillosis associated with adalimumab therapy.
    Gut. 2009;58:149.
    PubMed     Text format     Related articles   


  60. DECISIER M , Duhalde V, Faure P, Ammoury A, et al
    Rapid-onset febrile dermatosis.
    Gut. 2009;58:67.
    PubMed     Text format     Related articles   


  61. TAKEDATSU H , Taylor KD, Mei L, McGovern DP, et al
    Linkage of Crohn's disease-related serological phenotypes: NFKB1 haplotypes are associated with anti-CBir1 and ASCA, and show reduced NF-kappaB activation.
    Gut. 2009;58:60-7.
    PubMed     Text format     Related articles    Abstract available


    December 2008
  62. CAPRIOLI F , Stolfi C, Caruso R, Fina D, et al
    Transcriptional and post-translational regulation of Flip, an inhibitor of Fas-mediated apoptosis, in human gut inflammation.
    Gut. 2008;57:1674-80.
    PubMed     Text format     Related articles    Abstract available


    November 2008
  63. SHTEINGART S , Rapoport M, Grodzovski I, Sabag O, et al
    Therapeutic Potency of IL2-Caspase3 Targeted Treatment in a Murine Experimental Model of Inflammatory Bowel Disease (IBD).
    Gut. 2008.
    PubMed     Text format     Related articles    Abstract available


  64. FRAQUELLI M , Rigamonti C, Colombo M
    Authors' response re: "Production of IL12p70 and IL23 by monocyte-derived dendritic cells in children with inflammatory bowel disease".
    Gut. 2008;57:1630-1.
    PubMed     Text format     Related articles   



  65. Confocal chromoscopic endomicroscopy is superior to chromoscopy alone for the detection and characterisation of intraepithelial neoplasia in chronic ulcerative colitis (Gut 2008;57:196-204).
    Gut. 2008;57:1634.
    PubMed     Text format     Related articles   


  66. PINETON DE CHAMBRUN G , Vernier-Massouille G, Viget N, Colombel JF, et al
    Is detection of JC virus DNA in blood a valuable screening test for progressive multifocal leukoencephalopathy in Crohn's disease patients eligible for anti-alpha4 integrin therapy?
    Gut. 2008;57:1633-4.
    PubMed     Text format     Related articles   


  67. AGHDASSI A , Richter G, Simon P, Ringel J, et al
    A male patient with ileitis and a calcifying small bowel lesion. Neuroendrocrine carcinoma.
    Gut. 2008;57:1554.
    PubMed     Text format     Related articles   


  68. BRENNER DJ
    Should computed tomography be the modality of choice for imaging Crohn's disease in children? The radiation risk perspective.
    Gut. 2008;57:1489-90.
    PubMed     Text format     Related articles   


  69. DESMOND AN , O'Regan K, Curran C, McWilliams S, et al
    Crohn's disease: factors associated with exposure to high levels of diagnostic radiation.
    Gut. 2008;57:1524-9.
    PubMed     Text format     Related articles    Abstract available


    October 2008
  70. FIDDER HH , Schnitzler F, Ferrante M, Noman M, et al
    Long-Term Safety of Infliximab for the treatment of Inflammatory Bowel Disease: A Single Center Cohort Study.
    Gut. 2008.
    PubMed     Text format     Related articles    Abstract available


  71. KRUIS W , Kiudelis G, Racz I, Gorelov IA, et al
    Once-daily versus three-times-daily mesalazine granules in active ulcerative colitis: A double-blind, double-dummy, randomised non-inferiority trial.
    Gut. 2008.
    PubMed     Text format     Related articles    Abstract available


  72. DAMEN GM , van Lierop P, de Ruiter L, Escher JC, et al
    Production of IL12p70 and IL23 by monocyte-derived dendritic cells in children with inflammatory bowel disease.
    Gut. 2008;57:1480.
    PubMed     Text format     Related articles   


  73. SHALE M , Ghosh S
    Beyond TNF, Th1 and Th2 in inflammatory bowel disease.
    Gut. 2008;57:1349-51.
    PubMed     Text format     Related articles   


  74. CLIFFORD DB
    Natalizumab and PML: a risky business?
    Gut. 2008;57:1347-9.
    PubMed     Text format     Related articles   


  75. VERBEECK J , Van Assche G, Ryding J, Wollants E, et al
    JC viral loads in patients with Crohn's disease treated with immunosuppression: can we screen for elevated risk of progressive multifocal leukoencephalopathy?
    Gut. 2008;57:1393-7.
    PubMed     Text format     Related articles    Abstract available


  76. BITTON A , Dobkin PL, Edwardes MD, Sewitch MJ, et al
    Predicting relapse in Crohn's disease: a biopsychosocial model.
    Gut. 2008;57:1386-92.
    PubMed     Text format     Related articles    Abstract available


    September 2008
  77. BERNSTEIN CN
    Surveillance programmes for colorectal cancer in inflammatory bowel disease: have we got it right?
    Gut. 2008;57:1194-6.
    PubMed     Text format     Related articles   


  78. PETERSON N , Guthery S, Denson L, Lee J, et al
    Genetic variants in the autophagy pathway contribute to paediatric Crohn's disease.
    Gut. 2008;57:1336-7.
    PubMed     Text format     Related articles   


  79. DOST D , van Leerdam ME, van Dekken H, Weimar W, et al
    Crohn's-like enterocolitis associated with mycophenolic acid treatment.
    Gut. 2008;57:1330.
    PubMed     Text format     Related articles   


  80. MASSEY DC , Bredin F, Parkes M
    Use of sirolimus (rapamycin) to treat refractory Crohn's disease.
    Gut. 2008;57:1294-6.
    PubMed     Text format     Related articles    Abstract available


  81. BERNSTEIN CN , Shanahan F
    Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases.
    Gut. 2008;57:1185-91.
    PubMed     Text format     Related articles   


    August 2008
  82. POWELL N , Jung SE, Krishnan B
    Clostridium difficile infection and inflammatory bowel disease: a marker for disease extent?
    Gut. 2008;57:1183-4.
    PubMed     Text format     Related articles   


  83. BUNING J , Homann N, von Smolinski D, Borcherding F, et al
    Helminths as governors of inflammatory bowel disease.
    Gut. 2008;57:1182-3.
    PubMed     Text format     Related articles   


  84. SMITH S , Shaw J, Nathwani D
    Nitazoxanide for cryptosporidial infection in Crohn's disease.
    Gut. 2008;57:1179-80.
    PubMed     Text format     Related articles   


    July 2008
  85. SHALE M , Kanfer E, Panaccione R, Ghosh S, et al
    Hepatosplenic T-Cell Lymphoma in Inflammatory Bowel Disease.
    Gut. 2008.
    PubMed     Text format     Related articles    Abstract available


  86. KOBAYASHI T , Okamoto S, Hisamatsu T, Kamada N, et al
    IL-23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease.
    Gut. 2008.
    PubMed     Text format     Related articles    Abstract available


  87. STRAUB RH , Grum F, Strauch U, Capellino S, et al
    Anti-inflammatory role of sympathetic nerves in chronic intestinal inflammation.
    Gut. 2008;57:911-21.
    PubMed     Text format     Related articles    Abstract available


  88. SIMMS LA , Doecke JD, Walsh MD, Huang N, et al
    Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease.
    Gut. 2008;57:903-10.
    PubMed     Text format     Related articles    Abstract available


    June 2008
  89. HENRIKSEN M , Jahnsen J, Lygren I, Stray N, et al
    C -Reactive Protein: A Predictive Factor And Marker Of Inflammation In Inflammatory Bowel Disease Results From A Prospective Population-Based Study.
    Gut. 2008;.
    PubMed     Text format     Related articles    Abstract available


  90. NOBLE CL , Abbas AR, Cornelius J, Lees CW, et al
    Regional Variation in Gene Expression in the Healthy Colon is Dysregulated in Ulcerative Colitis.
    Gut. 2008;.
    PubMed     Text format     Related articles    Abstract available


  91. DERIJKS LJ , van Helden RB, Hommes DW, Stokkers PC, et al
    Dosing azathioprine in thiopurine S-methyltransferase deficient inflammatory bowel disease patients.
    Gut. 2008;57:872.
    PubMed     Text format     Related articles   


  92. XAVIER RJ , Huett A, Rioux JD
    Autophagy as an important process in gut homeostasis and Crohn's disease pathogenesis.
    Gut. 2008;57:717-20.
    PubMed     Text format     Related articles   


  93. CAMPREGHER C , Luciani MG, Gasche C
    Activated neutrophils induce an hMSH2-dependent G2/M checkpoint arrest and replication errors at a (CA)13-repeat in colon epithelial cells.
    Gut. 2008;57:780-7.
    PubMed     Text format     Related articles    Abstract available   Free Full Text


    May 2008
  94. FASSI DE , Nielsen CH, Kjeldsen J, Clemmensen O, et al
    Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' disease.
    Gut. 2008;57:714-5.
    PubMed     Text format     Related articles   


  95. TILG H , Moschen AR, Kaser A, Pines A, et al
    Gut, inflammation and osteoporosis: basic and clinical concepts.
    Gut. 2008;57:684-94.
    PubMed     Text format     Related articles    Abstract available


  96. WATERMEYER G , Epstein D, Hlatshwayo S, George D, et al
    Dysphagia and a skin rash.
    Gut. 2008;57:672.
    PubMed     Text format     Related articles   


  97. DI SABATINO A , Pickard KM, Rampton D, Kruidenier L, et al
    Blockade of transforming growth factor beta upregulates T-box transcription factor T-bet, and increases T helper cell type 1 cytokine and matrix metalloproteinase-3 production in the human gut mucosa.
    Gut. 2008;57:605-12.
    PubMed     Text format     Related articles    Abstract available


    April 2008
  98. STANGE EF , Travis SP
    The European Consensus on ulcerative colitis: new horizons?
    Gut. 2008;.
    PubMed     Text format     Related articles    Abstract available


  99. MANOSA M , Domenech E, Marin L, Olive A, et al
    Adalimumab-induced lupus erythematosus in Crohn's disease patients previously treated with infliximab.
    Gut. 2008;57:559.
    PubMed     Text format     Related articles   


  100. MEDDINGS J
    The significance of the gut barrier in disease.
    Gut. 2008;57:438-40.
    PubMed     Text format     Related articles   


    March 2008
  101. BUENING J , Homann N, von Smolinski D, Borcherding F, et al
    Helminths as Governors of Inflammatory Bowel Disease.
    Gut. 2008;.
    PubMed     Text format     Related articles    Abstract available


  102. VAN DEN BROEK FJ , Fockens P, van Eeden S, Reitsma JB, et al
    Endoscopic tri-modal imaging for surveillance in ulcerative colitis: Randomized comparison of high resolution endoscopy and autofluorescence imaging for neoplasia detection; and evaluation of narrow band imaging for classification of lesions.
    Gut. 2008;.
    PubMed     Text format     Related articles    Abstract available   Free Full Text


  103. LUTGENS MW , Vleggaar FP, Schipper ME, Stokkers PC, et al
    High Frequency of Early Colorectal Cancer in Inflammatory Bowel Disease.
    Gut. 2008;.
    PubMed     Text format     Related articles    Abstract available


  104. LEPAGE P , Colombet J, Marteau P, Sime-Ngando T, et al
    Dysbiosis in inflammatory bowel disease: a role for bacteriophages?
    Gut. 2008;57:424-5.
    PubMed     Text format     Related articles   


  105. PEYRIN-BIROULET L
    Is ileocaecal Crohn's disease L1 or L3 according to the Montreal classification?
    Gut. 2008;57:427.
    PubMed     Text format     Related articles   


  106. BOURIKAS LA , Kourbeti IS, Koutsopoulos AV, Koutroubakis IE, et al
    Disseminated tuberculosis in a Crohn's disease patient on anti-TNF alpha therapy despite chemoprophylaxis.
    Gut. 2008;57:425.
    PubMed     Text format     Related articles   


    February 2008
  107. KAMM MA , Lichtenstein GR, Sandborn WJ, Schreiber S, et al
    Randomised trial of once- or twice-daily MMXTM mesalazine for maintenance of remission in ulcerative colitis.
    Gut. 2008;.
    PubMed     Text format     Related articles    Abstract available   Free Full Text


  108. HURLSTONE DP , Kiesslich R, Thomson M, Atkinson R, et al
    Confocal chromoscopic endomicroscopy is superior to chromoscopy alone for the detection and characterisation of intraepithelial neoplasia in chronic ulcerative colitis.
    Gut. 2008;57:196-204.
    PubMed     Text format     Related articles    Abstract available


  109. STONE CD
    Prognosis in Clostridium difficile infection complicating inflammatory bowel disease.
    Gut. 2008;57:150-2.
    PubMed     Text format     Related articles   


  110. BHAGRA S , Arora AS
    Fever and an inguinal swelling: pyoderma gangrenosum.
    Gut. 2008;57:204.
    PubMed     Text format     Related articles   


  111. CASSINOTTI A , Annaloro C, Ardizzone S, Onida F, et al
    Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease.
    Gut. 2008;57:211-7.
    PubMed     Text format     Related articles    Abstract available


    January 2008
  112. VIGET N , Vernier-Massouille G, Salmon-Ceron D, Yazdanpanah Y, et al
    Opportunistic infections attributed to immunomodulator agents and tumour necrosis factor antagonists in patients with inflammatory bowel disease: prevention and diagnosis.
    Gut. 2008;.
    PubMed     Text format     Related articles    Abstract available   Free Full Text


  113. FERRIER L
    Significance of increased human colonic permeability in response to corticotrophin-releasing hormone (CRH).
    Gut. 2008;57:7-9.
    PubMed     Text format     Related articles   


  114. VAN KRUININGEN HJ , Colombel JF
    The forgotten role of lymphangitis in Crohn's disease.
    Gut. 2008;57:1-4.
    PubMed     Text format     Related articles    Abstract available


    December 2007

  115. Crohn's disease or abdominal tuberculosis?
    Gut. 2007;56:1757-8.
    PubMed     Text format     Related articles   


  116. SPILLER R
    Chronic diarrhoea.
    Gut. 2007;56:1756-7.
    PubMed     Text format     Related articles   


  117. KUGATHASAN S , Saubermann LJ, Smith L, Kou D, et al
    Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease.
    Gut. 2007;56:1696-705.
    PubMed     Text format     Related articles    Abstract available


  118. CALON A , Gross I, Lhermitte B, Martin E, et al
    Different effects of the Cdx1 and Cdx2 homeobox genes in a murine model of intestinal inflammation.
    Gut. 2007;56:1688-95.
    PubMed     Text format     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: